MidMarketNow
Get the Weekly

Humanoid raises ~EUR 183m as UK robotics heats up

#Humanoid robotics#Humanoid Series A#Prime Movers Lab#Bosch investment#Schaeffler venture
By SofiaAI-generated3 min read

Deal at a glance

Type
funding · Series A
Enterprise value
€183.1M
Original amount
GBP 152M
Target
Humanoid
Acquirer
Investor
Sector
Technology
Region
Announced

Deal-ID: MMN-000901

Key facts

Buyer
Target
Humanoid
Sector
Technology
Geography
Deal volume
€183.1M
Date

Humanoid robotics is moving from lab demo to factory and logistics workflow, and investors are increasingly paying for platforms that can automate repetitive, variable tasks without rebuilding the environment. UK-based robotics startup Humanoid has raised $152 million (about ~EUR 183m) in a Series A round at a $1.35 billion post-money valuation, according to Reuters.

The round was led by Prime Movers Lab and included participation from Bosch, Schaeffler, Fubon Financial Holding Venture Capital, and Aglaé Ventures. Multiple outlets described Humanoid as Europe’s first pure-play humanoid robotics unicorn.

Why this round fits the current market

The funding lands squarely in the broader humanoid robotics boom, where the commercial pitch is simple: robots that can augment human labour in environments that are currently too unstructured for traditional industrial automation. The difference versus classic robotics is not just the form factor, but the intended deployment model: general-purpose manipulation and mobility that can be trained and updated, rather than a single fixed-purpose cell.

Humanoid’s investor mix is the other signal. Reuters and Forbes both highlighted Bosch and Schaeffler as industrial giants backing the company. Forbes additionally reported that Bosch and Schaeffler were not only investors but also Humanoid customers. That customer-investor overlap matters commercially because it suggests early deployment pathways and a clearer definition of “who pays” and “what workflow” than many early-stage robotics stories.

Strategic-industrial support changes the GTM calculus

For humanoid robotics companies, go-to-market friction is usually the hard part: long sales cycles, integration risk, safety and compliance requirements, and the need to prove uptime and unit economics in real operations. Industrial participation can de-risk several of those constraints:

  • Reference deployments: credible end-user environments shorten credibility-building cycles with other industrial buyers.
  • Integration depth: industrial partners can influence interfaces, maintenance models, and deployment requirements, increasing the chance of repeatable implementations.
  • Procurement reality: strategic customers understand how capex, opex, and service contracts are actually bought inside factories and logistics networks.

The trade-off is that “strategic” money can pull product direction toward specific use cases or partner requirements. The winners typically balance early anchor customers with a roadmap that still supports broader distribution.

UK narrative: strong ingredients, leadership still to be proven

UK-focused coverage has positioned Humanoid as evidence of British strength in AI and robotics, with the company saying it is positioning the UK as a global leader in robotics innovation. Policy and ecosystem commentary is more cautious. A TechUK article argues the UK has strong academic research and AI expertise, and points to institutions such as the National Robotarium and ARIA, but also notes the country is not yet in a position of clear global leadership.

In that context, Humanoid’s round is best read less as definitive proof of national leadership and more as a data point that the UK can produce globally financed robotics companies when the team, story, and early customer signals align.

What the financing likely supports next

Humanoid’s total funding was reported by Reuters and Forbes at $270 million. While the company has not detailed a full use-of-proceeds breakdown in the cited coverage, a Series A of this size in humanoid robotics typically implies an acceleration of (inference):

  • engineering and hardware iteration cycles,
  • safety, reliability, and field testing in real customer environments,
  • initial deployment operations (installation, monitoring, service), and
  • commercial capacity to convert pilots into multi-site rollouts.

The key question for any humanoid platform is whether it can turn high-profile pilots into a repeatable deployment playbook that reduces marginal implementation cost over time.

What this enables

  • Faster path from prototype to customer-grade deployments, supported by industrial participants.
  • Stronger enterprise credibility if customer-investor relationships translate into measurable production use.
  • Momentum for UK and European robotics financing as investors seek exposure to labour-augmentation themes.

What to watch

  • Evidence of repeatable deployments beyond anchor customers, not just bespoke integrations.
  • Reliability, safety and service model maturity, which will dictate real-world retention.
  • How tightly Bosch and Schaeffler shape product direction, and whether the platform remains broadly addressable.
  • Competitive pressure from other well-capitalised humanoid robotics teams as the category crowds.

Companies & investors in this story

More in this sector

We use privacy-respecting product analytics to understand how readers use MidMarketNow and improve it. No personal data (email, IP) is sent. See our privacy policy.